Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

6.03USD
24 Apr 2015
Change (% chg)

$-0.38 (-5.85%)
Prev Close
$6.41
Open
$6.40
Day's High
$6.43
Day's Low
$6.01
Volume
174,593
Avg. Vol
208,588
52-wk High
$7.83
52-wk Low
$3.15

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. is a medicine developing company. The Company is engaged in developing medicines for oncology. Its focus for Progenics is targeted therapeutics and imaging agents. The Company’s clinical development efforts center on late-stage oncology assets. Its principal clinical-stage product candidates in... (more)

Overall

Beta: 1.66
Market Cap(Mil.): $446.04
Shares Outstanding(Mil.): 69.64
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 490.80 41.04 41.69
EPS (TTM): 0.01 -- --
ROI: 3.36 16.81 16.15
ROE: 4.33 17.31 16.96
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks